Evli High Yield vs UBS Lux Equity Fund Biotech USD

Evli High Yield vs UBS Lux Equity Fund Biotech USD

1. Evli High Yield

  • Security

    Evli High Yield B

  • Fee

    1.11%

  • ISIN

    FI0008803929

  • Holdings

    16

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 16 holdings in Evli High Yield, where the largest holding is Iliad Holding (1.37), followed by Lorca Telecom Bondco (1.36) and BPCE (1.27). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Evli High Yield and UBS Lux Equity Fund Biotech USD.

Evli High Yield UBS Lux Equity Fund Biotech USD
1. Iliad Holding SAS
France
1.37 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Lorca Telecom Bondco SAU
Spain
1.36 %
2. Moderna Inc
9.21 %
3. BPCE SA
France
1.27 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Allianz SE
Germany
1.16 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Commerzbank AG
Germany
1.1 %
5. AbbVie Inc
USA
4.91 %
6. Zegona Finance Plc
UK
1.08 %
6. Gilead Sciences Inc
USA
4.66 %
7. Dynamo Newco II GmbH
Germany
1.05 %
7. Amgen Inc
USA
4.43 %
8. Nidda Healthcare Holding GmbH
Germany
1.05 %
8. BioNTech SE
4.13 %
9. Telefónica Europe BV
Netherlands
1.02 %
9. Karuna Therapeutics Inc
3.75 %
10. UPCB Finance VII Ltd
Cayman Islands
1.02 %
-
11. Progroup AG
Switzerland
1 %
-
12. Fabbrica Italiana Sintetici SpA
Italy
1 %
-
13. Intrum AB
0.98 %
-
14. NTI Group Holding ApS
Denmark
0.98 %
-
15. Boels Topholding NV
Netherlands
0.95 %
-
16. Eroski Sociedad Cooperativa
Spain
0.92 %
-

The list of fund holdings was last updated on July 25, 2025.